MacroGenics
MGNX
#8652
Rank
โ‚ฌ0.20 B
Marketcap
3,24ย โ‚ฌ
Share price
-7.73%
Change (1 day)
128.26%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚ฌ0.17 Billion

According to MacroGenics's latest financial reports the company's total liabilities are โ‚ฌ0.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ0.17 B22.45%
2024-12-31โ‚ฌ0.13 B6.08%
2023-12-31โ‚ฌ0.13 B2.19%
2022-12-31โ‚ฌ0.12 B52.86%
2021-12-31โ‚ฌ84.43 M25.34%
2020-12-31โ‚ฌ67.36 M-7.83%
2019-12-31โ‚ฌ73.08 M-6.32%
2018-12-31โ‚ฌ78.01 M25.41%
2017-12-31โ‚ฌ62.21 M53.93%
2016-12-31โ‚ฌ40.41 M-3.79%
2015-12-31โ‚ฌ42 M-2.87%
2014-12-31โ‚ฌ43.24 M27.44%
2013-12-31โ‚ฌ33.93 M-27.58%
2012-12-31โ‚ฌ46.85 M-24.09%
2011-12-31โ‚ฌ61.72 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚ฌ102.71 B 59,497.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ74.81 B 43,310.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ73.00 B 42,261.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ28.78 B 16,601.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ72.51 B 41,976.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ58.16 B 33,648.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.19 B 12.48%๐Ÿ‡บ๐Ÿ‡ธ USA